OxoN Medica
Founded Year
1999Stage
Angel | DeadTotal Raised
$3.9MLast Raised
$3.9MAbout OxoN Medica
Developer of drugs for diseases of endothelial dysfunction where interaction between oxidative stress and physiological mediators contributes to the pathology. The company currently has three lead compounds in the advanced stages of pre-clinical development. The targeted therapeutic areas for clinical use of these compounds include diabetic vascular and renal complications, ocular disorders, and respiratory disorders. The company is currently focusing on developing drugs for ocular diseases and its current research will identify new compounds for future development.
OxoN Medica Frequently Asked Questions (FAQ)
When was OxoN Medica founded?
OxoN Medica was founded in 1999.
What is OxoN Medica's latest funding round?
OxoN Medica's latest funding round is Angel.
How much did OxoN Medica raise?
OxoN Medica raised a total of $3.9M.